Published in Vestn Ross Akad Med Nauk on January 01, 2008
Hypothalamic mechanisms of ageing and of specific age pathology--II. on the sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in adaptive homestasis. Exp Gerontol (1979) 1.39
Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer. J Cancer Res Clin Oncol (2004) 1.08
Glucose-induced effects and joker function of glucose: endocrine or genotoxic prevalence? Horm Metab Res (2006) 0.99
The creation of linear contiguous lesions in the atria with an expandable loop catheter. J Am Coll Cardiol (1999) 0.95
Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer. J Cancer Res Clin Oncol (2003) 0.94
Preliminary evidence on metabolic rehabilitation of cancer patients. Arch Geschwulstforsch (1988) 0.91
CYP19 gene polymorphism in endometrial cancer patients. J Cancer Res Clin Oncol (2001) 0.87
[Effect of fenformin on the blastomogenic action of 1,2-dimethylhydrazine in rats]. Vopr Onkol (1980) 0.87
Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology (1982) 0.84
Mammary tumors in HER-2/NEU mice are characterized by low content of estrogen receptors-alpha and absence of progesterone receptors. Bull Exp Biol Med (2003) 0.84
[Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer]. Mol Biol (Mosk) (2004) 0.84
[Excretion of cyclic adenosine monophosphate in breast and lung cancer]. Vopr Onkol (1976) 0.82
[Kinetic features of ascites and solid Ehrlich tumors]. Vopr Onkol (2009) 0.81
[Role of Ki-67, mutated gene-suppressor p53 and HER-2neu oncoprotein in the prognosis for the clinical course of bladder cancer]. Vopr Onkol (2006) 0.79
[A polymorphism study of the CYP19 gene in endometrial cancer patients]. Vopr Onkol (2000) 0.79
[Aromatase (estrogen synthetase) gene expression in human leukocytes]. Ross Fiziol Zh Im I M Sechenova (2000) 0.79
Comparative study of blood insulin levels in breast and endometrial cancer patients. Neoplasma (1997) 0.79
Endocrine-metabolic criteria for distinguishing two pathogenetic types of breast cancer. Neoplasma (1977) 0.78
Expression of estrogen receptors-alpha and -beta in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy. Bull Exp Biol Med (2004) 0.78
[Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes]. Vestn Ross Akad Med Nauk (2013) 0.78
[Age-related changes in adenylate cyclase activity, lipid composition and lipid peroxidation in rat intestinal mucosa: comparison with the frequency of spontaneous tumors]. Vopr Onkol (1985) 0.78
[Some kinetic characteristics of cervical cancer]. Vopr Onkol (2009) 0.78
[Morphology of experimental malignant hemangioendothelioma]. Vopr Onkol (1990) 0.77
[Effect of phenformin on mammary gland tumor induction in rats]. Vopr Onkol (1974) 0.77
Catecholestrogens excretion in smoking and non-smoking postmenopausal women receiving estrogen replacement therapy. J Steroid Biochem Mol Biol (2000) 0.77
[Polymorphism of glucose intolerance and insulin resistance susceptibility genes in oncological patients]. Mol Biol (Mosk) (2009) 0.77
[Characteristics of dyslipidemia in cancer patients]. Vopr Onkol (1986) 0.77
[The influence of metformin and N-acetylcysteine on mammographic density in postmenopausal women]. Vopr Onkol (2012) 0.77
[Mathematical evaluation of prognostic significance of clinico-morphological and immunohistochemical features of endometrioid adenocarcinoma]. Vopr Onkol (2007) 0.77
[Endometrial cancer, estrogens and metabolic syndrome: scenario becomes more complicated]. Vopr Onkol (2014) 0.76
[Exosomal intercellular communication system and its role in the process of metastatic dissemination]. Vopr Onkol (2014) 0.76
[Relation of blood lipids and insulin to body fat content, body surface area and state of the subcutaneous fatty tissue in patients with breast and lung cancer]. Vopr Onkol (1985) 0.76
[Cognitive function in patients with endometrial and colorectal cancer: connection with hormonal and metabolic status]. Vopr Onkol (2004) 0.76
Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects. Exp Oncol (2006) 0.76
[Immunohistochemical profile of endometrioid adenocarcinoma of the uterus: ER, PR, HER-2, Ki-67 and their prognostic value]. Arkh Patol (2005) 0.76
[Features of carcinogenesis and aging in knockout male mice PARP-1]. Vopr Onkol (2010) 0.76
[Immunohistochemical examination of MSH2, PMS2, MLH1, MSH6 compared with the analysis of microsatellite instability in colon adenocarcinoma]. Vopr Onkol (2014) 0.76
Aromatase (CYP19) expression in tumor-infiltrating lymphocytes and blood mononuclears. J Cancer Res Clin Oncol (2002) 0.76
Hyperinsulinemia as a factor modifying sensitivity of endometrial carcinoma to hormonal influences. Eur J Gynaecol Oncol (1993) 0.76
[Registry-based analysis of cancer and diabetes combination: prevalence and features]. Vopr Onkol (2007) 0.76
[Effectiveness of aromatase inhibitors in comparison with metformin for neoadjuvant treatment in patients with endometrial cancer]. Vopr Onkol (2011) 0.76
Induction of the estrogen effect-switching phenomenon by ethanol and its correction. Neurosci Behav Physiol (2002) 0.76
[Effect of thyroxine on the hypothalamic concentration of biogenic amines in rats of different ages]. Fiziol Zh SSSR Im I M Sechenova (1978) 0.76
Ability of lymphocytes infiltrating breast-cancer tissue to convert androstenedione. Int J Cancer (1998) 0.76
Hormone-metabolic status in moderately smoking breast cancer patients. Acta Oncol (1997) 0.76
[The excretion of classical estrogens and total phenolsteroids in patients with uterine cancer]. Vopr Onkol (1967) 0.76
Estrogen content and DNA unwinding in tumor and normal endometrial tissue of aging endometrial cancer patients. Mutat Res (1996) 0.75
[Anahormone chimeras. Conjugates of melanocyte-stimulating pituitary hormone (MSH) with human melanoma antigens]. Dokl Akad Nauk SSSR (1974) 0.75
[Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes]. Vopr Onkol (2012) 0.75
Professor Vladimir Dilman. Int J Obes Relat Metab Disord (1995) 0.75
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin]. Vopr Onkol (1975) 0.75
[A decrease in body weight, cholesterol and blood sugar under the influence of phenformin (phenylbiguanide) in patients with cancer and atherosclerosis]. Vopr Onkol (1972) 0.75
Study of tobacco smoke influence on content of estrogens and DNA flow cytometry data in uterine tissue of rats of different age. Horm Metab Res (1999) 0.75
[Effect of tamoxifen on the content of cytoplasmic steroid hormone receptors of the tumor in patients with cancer of the corpus uteri]. Vopr Onkol (1989) 0.75
[Immunohistochemical study of the proliferation of breast cancer cells based on the expression of proliferating cell nuclear antigen (PCNA)]. Vopr Onkol (1998) 0.75
Effect of ethanol on uterotropic action of estrogens. Bull Exp Biol Med (2000) 0.75
[Catechol estrogen excretion in women receiving estrogen replacement therapy]. Biull Eksp Biol Med (1999) 0.75
[State of immunological reactivity in breast cancer patients receiving prednisolone treatment]. Vopr Onkol (1979) 0.75
[Effect of tobacco smoke on the level of estrogens and DNA in the rat uterus]. Ross Fiziol Zh Im I M Sechenova (1999) 0.75
[Tamoxifen-induced progesterone receptors in breast tumors]. Vopr Onkol (1991) 0.75
Effect of oxyprogesterone caproate, tamoxifen and their combination on the level of steroid hormone receptors in the tumor, and some parameters of the reproductive system in patients with endometrial cancer. Clin Exp Obstet Gynecol (1990) 0.75
[Comparative study of the proliferation (by detection of Ki-67 antigen) and activity of nucleolar organizer regions in breast cancer cells]. Vopr Onkol (1998) 0.75
Influence of tobacco smoke on DNA unwinding and uterotrophic effect of estrogens in rats. Cancer Lett (1998) 0.75
[Metabolic effect of tobacco smoke and "switching" the estrogen effect: mechanism of increased genotoxicity]. Vestn Ross Akad Med Nauk (2001) 0.75
[Interrelationship between response to neoadjuvant hormone therapy and hormonal-metabolic status in breast cancer patients]. Vopr Onkol (2001) 0.75
[Induction by ethanol of 'phenomenon of switching estrogen effect' and its correction]. Ross Fiziol Zh Im I M Sechenova (2001) 0.75
[The nature of hyperinsulinemia (insulin resistance) in endometrial carcinoma: of plasma levels of insulin and c-peptide]. Vopr Onkol (2000) 0.75